Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, United Kingdom; and
Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, United Kingdom; and.
J Immunol. 2020 May 1;204(9):2374-2379. doi: 10.4049/jimmunol.1901457. Epub 2020 Mar 27.
We previously showed that anti-neutrophil extracellular trap (NET) rheumatoid arthritis (RA)-rmAbs derived from CD19 B cells within RA human synovial tissues frequently react against NETs. In this study, we aimed to characterize the importance of affinity maturation via somatic hypermutation (SHM) within the Ig variable H (VH) and variable L (VL) chains and Fab--linked glycosylation in RA synovial B cell clones reactive to NETs and NET-derived Ags such as citrullinated histones. Selected anti-NET RA-rmAbs derived from synovial RA CD19 B cells were subjected to overlap-PCR to generate germline (GL; VH and VL reverted into GL), hybrid clones (VH/VL region reverted into GL), and -glycosylation mutants (N→Q) and analyzed for anti-NETs and citrullinated histones (cit-H2B) immunoreactivity. Anti-NET/cit-H2B immunoreactivity of selected RA-rmAbs was abrogated in the VH and VL GL counterpart. In RA B cell hybrid clone RA015/11.88 and RA056/11.23.2, NET and/or cit-H2B immunoreactivity was solely dependent on SHM in the IgVH region whereas RA B cell hybrid clone RA015/11.91 required affinity maturation of both VH and VL for efficient binding to cit-H2B. In 7/80 RA-rmAb, SHM resulted in ex novo -glycosylation sites in VH and/or VL regions. Removal of Fab-linked glycans in RA056/11.23.2 in the -mutant counterpart resulted in 90% reduction in immunoreactivity to cit-H2B. Thus, SHM in the IgVH and/or VL regions of RA synovial B cells is necessary for the immunoreactivity to NET-Ags. Fab--linked-glycosylation introduction sites are observed in a minority of anti-NET B cell clones but can strongly influence NET-Ag binding.
我们之前已经表明,源自 RA 人类滑膜组织中 CD19 B 细胞的抗中性粒细胞胞外诱捕网(NET)类风湿关节炎(RA)-rmAbs 通常会与 NET 反应。在这项研究中,我们旨在研究 Ig 可变 H(VH)和可变 L(VL)链以及 Fab 连接的糖基化中的体细胞超突变(SHM)在对 NET 和 NET 衍生抗原(如瓜氨酸化组蛋白)有反应的 RA 滑膜 B 细胞克隆中的重要性。从滑膜 RA CD19 B 细胞中选择的抗-NET RA-rmAbs 进行重叠-PCR,生成种系(GL;VH 和 VL 恢复为 GL)、杂交克隆(VH/VL 区域恢复为 GL)和 -糖基化突变体(N→Q),并分析其对 NET 和瓜氨酸化组蛋白(cit-H2B)的免疫反应性。选定的 RA-rmAbs 的抗-NET/cit-H2B 免疫反应性在 VH 和 VL GL 对应物中被消除。在 RA B 细胞杂交克隆 RA015/11.88 和 RA056/11.23.2 中,NET 和/或 cit-H2B 免疫反应性仅依赖于 IgVH 区域中的 SHM,而 RA B 细胞杂交克隆 RA015/11.91 则需要 VH 和 VL 的亲和力成熟,以便有效地与 cit-H2B 结合。在 7/80 个 RA-rmAb 中,SHM 在 VH 和/或 VL 区域中产生新的糖基化位点。在 RA056/11.23.2 的 -突变体对应物中去除 Fab 连接的聚糖导致对 cit-H2B 的免疫反应性降低 90%。因此,RA 滑膜 B 细胞中 IgVH 和/或 VL 区域的 SHM 是对 NET-Ags 产生免疫反应所必需的。在少数抗-NET B 细胞克隆中观察到 Fab 连接的糖基化引入位点,但它们可以强烈影响 NET-Ag 结合。